Inhibition of the BGR-ABL tyrosine kinase for the treatment of chronic myeloid leukemia

被引：0
|
作者：
Coulombel, L [1 ]
机构：
[1] INSERM U474, F-75014 Paris, France
来源：
M S-MEDECINE SCIENCES | 2001年 / 17卷 / 8-9期
关键词：
D O I：
10.4267/10608/2038
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：952 / 953
页数：2
相关论文
共 50 条
  • [21] Tyrosine-kinase inhibition in treatment of chronic myeloid leukaemia
    Goldman, JM
    LANCET, 2000, 355 (9209): : 1031 - 1032
  • [22] Inhibition of isoprenylcysteine carboxylmethyltransferase augments BCR-ABL1 tyrosine kinase inhibition-induced apoptosis in chronic myeloid leukemia
    Sun, Wen Tian
    Xiang, Wei
    Ng, Bee Ling
    Asari, Kartini
    Bunte, Ralph M.
    Casey, Patrick J.
    Wang, Mei
    Chuah, Charles
    EXPERIMENTAL HEMATOLOGY, 2016, 44 (03) : 189 - 193
  • [23] Tyrosine kinase inhibition in acute myeloid leukemia
    Altman, Jessica K.
    Szilard, Amy K.
    Platanias, Leonidas C.
    LEUKEMIA & LYMPHOMA, 2013, 54 (07) : 1351 - 1352
  • [24] ABL tyrosine kinase inhibitor-induced pulmonary alveolar proteinosis in chronic myeloid leukemia
    Yoshimura, Mariko
    Kojima, Kensuke
    Tomimasu, Rika
    Fukushima, Noriyasu
    Hayashi, Shinichiro
    Sueoka, Eisaburo
    Kimura, Shinya
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 100 (06) : 611 - 614
  • [25] Heterocyclic Compounds as Bcr-Abl Tyrosine Kinase Inhibitors Against Chronic Myeloid Leukemia
    Gado, Sarah
    Hassan, Mohammed Al-Kassim
    Kisla, Mehmet Murat
    Ates-Alagoz, Zeynep
    MEDICINAL CHEMISTRY, 2024,
  • [26] ABL tyrosine kinase inhibitor-induced pulmonary alveolar proteinosis in chronic myeloid leukemia
    Mariko Yoshimura
    Kensuke Kojima
    Rika Tomimasu
    Noriyasu Fukushima
    Shinichiro Hayashi
    Eisaburo Sueoka
    Shinya Kimura
    International Journal of Hematology, 2014, 100 : 611 - 614
  • [27] Tyrosine kinase inhibitors in chronic myeloid leukemia
    Sawyers, CL
    Druker, B
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1999, 5 (02): : 63 - 69
  • [28] Bosutinib: a dual SRC/ABL kinase inhibitor for the treatment of chronic myeloid leukemia
    Keller, Gunhild
    Schafhausen, Philippe
    Brummendorf, Tim H.
    EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (05) : 489 - 497
  • [29] Successful treatment with ABL tyrosine kinase inhibitor for patients with acute myeloid leukemia with BCR-ABL1
    Takeuchi, Asako
    Kondo, Toshinori
    Tasaka, Taizo
    Yamada, Seiko
    Hirose, Tadashi
    Fukuda, Hirofumi
    Shimizu, Risa
    Matsuhashi, Yoshiko
    Kondo, Eisei
    Wada, Hideho
    LEUKEMIA RESEARCH REPORTS, 2021, 15
  • [30] Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitors
    Cortes, Jorge
    Jabbour, Elias
    Kantarjian, Hagop
    Yin, C. Cameron
    Shan, Jianqin
    O'Brien, Susan
    Garcia-Manero, Guillermo
    Giles, Francis
    Breeden, Megan
    Reeves, Nubia
    Wierda, William G.
    Jones, Dan
    BLOOD, 2007, 110 (12) : 4005 - 4011
12345